Accuray customers achieve top scores in aapm markerless lung target tracking challenge (match) using synchrony® technology on the radixact® and cyberknife® systems

Sunnyvale, calif., april 29, 2021 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today that accuray customers took the top two positions in the markerless lung target tracking challenge (match) experimental branch using the accuray synchrony lung tracking with respiratory modeling on the radixact®  next-generation tomotherapy®  platform, and cyberknife® system, respectively.
ARAY Ratings Summary
ARAY Quant Ranking